Histology and immunohistology of bone marrow biopsy in multiple myeloma

S. Pileri, S. Poggi, P. Baglioni, M. Montanari, E. Sabattini, P. Galieni, P. L. Tazzari, M. Gobbi, M. Cavo, B. Falini, H. Stein, S. Tura

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

B5-fixed/paraffin-embedded Jamshidi needle biopsies from 125 multiple myeloma patients were reviewed according to both morphological and immunohistological criteria. At microscopic examination, the following parameters were evaluated: i) grade of malignancy (low = 56; intermediate = 50; high = 19); ii) growth pattern (interstitial +/- sheets/nodules = 90; nodular = 13; packed marrow = 18; sarcomatous = 4); III) histological stage (I = 64; II = 35; III = 26). Comparison of the findings in trephine biopsies and aspirates showed that in 30% of the cases the latter led to an understimation of the tumor burden. Immunohistochemical determination of Ig easily allowed: i) differential diagnosis from exuberant reactive plasmacytosis; ii) recognition and counting of neoplastic plasma cells; iii) detection of minimal residual disease after treatment. Immunohistochemistry also confirmed phenotypic aberration of neoplastic plasma cells, showing positivity for CD45, EMA, and cytokeratins in 14%, 59%, and 25% of the cases, respectively. Furthermore, it displayed expression of the P-glycoprotein in 4/8 resistant cases. These findings underline that routinely processed Jamshidi needle biopsies can be of great value in the study of patients with multiple myeloma.

Original languageEnglish
Pages (from-to)52-59
Number of pages8
JournalEuropean Journal of Haematology, Supplement
Volume43
Issue number51
Publication statusPublished - 1989

Fingerprint

Needle Biopsy
Plasma Cells
Multiple Myeloma
Histology
Bone Marrow
Keratin-14
Biopsy
Residual Neoplasm
P-Glycoprotein
Tumor Burden
Paraffin
Differential Diagnosis
Immunohistochemistry
Growth
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Pileri, S., Poggi, S., Baglioni, P., Montanari, M., Sabattini, E., Galieni, P., ... Tura, S. (1989). Histology and immunohistology of bone marrow biopsy in multiple myeloma. European Journal of Haematology, Supplement, 43(51), 52-59.

Histology and immunohistology of bone marrow biopsy in multiple myeloma. / Pileri, S.; Poggi, S.; Baglioni, P.; Montanari, M.; Sabattini, E.; Galieni, P.; Tazzari, P. L.; Gobbi, M.; Cavo, M.; Falini, B.; Stein, H.; Tura, S.

In: European Journal of Haematology, Supplement, Vol. 43, No. 51, 1989, p. 52-59.

Research output: Contribution to journalArticle

Pileri, S, Poggi, S, Baglioni, P, Montanari, M, Sabattini, E, Galieni, P, Tazzari, PL, Gobbi, M, Cavo, M, Falini, B, Stein, H & Tura, S 1989, 'Histology and immunohistology of bone marrow biopsy in multiple myeloma', European Journal of Haematology, Supplement, vol. 43, no. 51, pp. 52-59.
Pileri S, Poggi S, Baglioni P, Montanari M, Sabattini E, Galieni P et al. Histology and immunohistology of bone marrow biopsy in multiple myeloma. European Journal of Haematology, Supplement. 1989;43(51):52-59.
Pileri, S. ; Poggi, S. ; Baglioni, P. ; Montanari, M. ; Sabattini, E. ; Galieni, P. ; Tazzari, P. L. ; Gobbi, M. ; Cavo, M. ; Falini, B. ; Stein, H. ; Tura, S. / Histology and immunohistology of bone marrow biopsy in multiple myeloma. In: European Journal of Haematology, Supplement. 1989 ; Vol. 43, No. 51. pp. 52-59.
@article{454abec9e7664e1ab0102768e00dab08,
title = "Histology and immunohistology of bone marrow biopsy in multiple myeloma",
abstract = "B5-fixed/paraffin-embedded Jamshidi needle biopsies from 125 multiple myeloma patients were reviewed according to both morphological and immunohistological criteria. At microscopic examination, the following parameters were evaluated: i) grade of malignancy (low = 56; intermediate = 50; high = 19); ii) growth pattern (interstitial +/- sheets/nodules = 90; nodular = 13; packed marrow = 18; sarcomatous = 4); III) histological stage (I = 64; II = 35; III = 26). Comparison of the findings in trephine biopsies and aspirates showed that in 30{\%} of the cases the latter led to an understimation of the tumor burden. Immunohistochemical determination of Ig easily allowed: i) differential diagnosis from exuberant reactive plasmacytosis; ii) recognition and counting of neoplastic plasma cells; iii) detection of minimal residual disease after treatment. Immunohistochemistry also confirmed phenotypic aberration of neoplastic plasma cells, showing positivity for CD45, EMA, and cytokeratins in 14{\%}, 59{\%}, and 25{\%} of the cases, respectively. Furthermore, it displayed expression of the P-glycoprotein in 4/8 resistant cases. These findings underline that routinely processed Jamshidi needle biopsies can be of great value in the study of patients with multiple myeloma.",
author = "S. Pileri and S. Poggi and P. Baglioni and M. Montanari and E. Sabattini and P. Galieni and Tazzari, {P. L.} and M. Gobbi and M. Cavo and B. Falini and H. Stein and S. Tura",
year = "1989",
language = "English",
volume = "43",
pages = "52--59",
journal = "Scandinavian journal of haematology. Supplementum",
issn = "0902-4506",
publisher = "Wiley-Blackwell",
number = "51",

}

TY - JOUR

T1 - Histology and immunohistology of bone marrow biopsy in multiple myeloma

AU - Pileri, S.

AU - Poggi, S.

AU - Baglioni, P.

AU - Montanari, M.

AU - Sabattini, E.

AU - Galieni, P.

AU - Tazzari, P. L.

AU - Gobbi, M.

AU - Cavo, M.

AU - Falini, B.

AU - Stein, H.

AU - Tura, S.

PY - 1989

Y1 - 1989

N2 - B5-fixed/paraffin-embedded Jamshidi needle biopsies from 125 multiple myeloma patients were reviewed according to both morphological and immunohistological criteria. At microscopic examination, the following parameters were evaluated: i) grade of malignancy (low = 56; intermediate = 50; high = 19); ii) growth pattern (interstitial +/- sheets/nodules = 90; nodular = 13; packed marrow = 18; sarcomatous = 4); III) histological stage (I = 64; II = 35; III = 26). Comparison of the findings in trephine biopsies and aspirates showed that in 30% of the cases the latter led to an understimation of the tumor burden. Immunohistochemical determination of Ig easily allowed: i) differential diagnosis from exuberant reactive plasmacytosis; ii) recognition and counting of neoplastic plasma cells; iii) detection of minimal residual disease after treatment. Immunohistochemistry also confirmed phenotypic aberration of neoplastic plasma cells, showing positivity for CD45, EMA, and cytokeratins in 14%, 59%, and 25% of the cases, respectively. Furthermore, it displayed expression of the P-glycoprotein in 4/8 resistant cases. These findings underline that routinely processed Jamshidi needle biopsies can be of great value in the study of patients with multiple myeloma.

AB - B5-fixed/paraffin-embedded Jamshidi needle biopsies from 125 multiple myeloma patients were reviewed according to both morphological and immunohistological criteria. At microscopic examination, the following parameters were evaluated: i) grade of malignancy (low = 56; intermediate = 50; high = 19); ii) growth pattern (interstitial +/- sheets/nodules = 90; nodular = 13; packed marrow = 18; sarcomatous = 4); III) histological stage (I = 64; II = 35; III = 26). Comparison of the findings in trephine biopsies and aspirates showed that in 30% of the cases the latter led to an understimation of the tumor burden. Immunohistochemical determination of Ig easily allowed: i) differential diagnosis from exuberant reactive plasmacytosis; ii) recognition and counting of neoplastic plasma cells; iii) detection of minimal residual disease after treatment. Immunohistochemistry also confirmed phenotypic aberration of neoplastic plasma cells, showing positivity for CD45, EMA, and cytokeratins in 14%, 59%, and 25% of the cases, respectively. Furthermore, it displayed expression of the P-glycoprotein in 4/8 resistant cases. These findings underline that routinely processed Jamshidi needle biopsies can be of great value in the study of patients with multiple myeloma.

UR - http://www.scopus.com/inward/record.url?scp=0024835632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024835632&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 52

EP - 59

JO - Scandinavian journal of haematology. Supplementum

JF - Scandinavian journal of haematology. Supplementum

SN - 0902-4506

IS - 51

ER -